These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 22617423)
61. Genetic variability and lineage phylogeny of human papillomavirus type-16 and -53 based on the E6, E7, and L1 genes in Southwest China. Cao M; Chenzhang Y; Ding X; Zhang Y; Jing Y; Chen Z Gene; 2016 Oct; 592(1):49-59. PubMed ID: 27450917 [TBL] [Abstract][Full Text] [Related]
62. Human papillomavirus does not have a causal role in colorectal carcinogenesis. Lorenzon L; Mazzetta F; Pilozzi E; Uggeri G; Torrisi MR; Ferri M; Ziparo V; French D World J Gastroenterol; 2015 Jan; 21(1):342-50. PubMed ID: 25574110 [TBL] [Abstract][Full Text] [Related]
63. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347 [TBL] [Abstract][Full Text] [Related]
64. Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. Wang X; Helfer CM; Pancholi N; Bradner JE; You J J Virol; 2013 Apr; 87(7):3871-84. PubMed ID: 23365439 [TBL] [Abstract][Full Text] [Related]
65. The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase. Bellanger S; Tan CL; Nei W; He PP; Thierry F J Virol; 2010 Jan; 84(1):437-44. PubMed ID: 19828607 [TBL] [Abstract][Full Text] [Related]
66. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly. Boon SS; Chen Z; Li J; Lee KYC; Cai L; Zhong R; Chan PKS BMC Cancer; 2019 Dec; 19(1):1211. PubMed ID: 31830929 [TBL] [Abstract][Full Text] [Related]
67. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. Dong G; Broker TR; Chow LT J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341 [TBL] [Abstract][Full Text] [Related]
68. Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Okoye A; Cordano P; Taylor ER; Morgan IM; Everett R; Campo MS Virus Res; 2005 Mar; 108(1-2):1-14. PubMed ID: 15681049 [TBL] [Abstract][Full Text] [Related]
69. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424 [TBL] [Abstract][Full Text] [Related]
70. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes. Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489 [TBL] [Abstract][Full Text] [Related]
71. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117 [TBL] [Abstract][Full Text] [Related]
72. Influence of physiologic folate deficiency on human papillomavirus type 16 (HPV16)-harboring human keratinocytes in vitro and in vivo. Xiao S; Tang YS; Khan RA; Zhang Y; Kusumanchi P; Stabler SP; Jayaram HN; Antony AC J Biol Chem; 2012 Apr; 287(15):12559-77. PubMed ID: 22351779 [TBL] [Abstract][Full Text] [Related]
73. Requirement of E7 oncoprotein for viability of HeLa cells. Nishimura A; Nakahara T; Ueno T; Sasaki K; Yoshida S; Kyo S; Howley PM; Sakai H Microbes Infect; 2006 Apr; 8(4):984-93. PubMed ID: 16500131 [TBL] [Abstract][Full Text] [Related]
74. Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression. Fertey J; Ammermann I; Winkler M; Stöger R; Iftner T; Stubenrauch F J Virol; 2010 Sep; 84(18):9505-15. PubMed ID: 20631145 [TBL] [Abstract][Full Text] [Related]
75. Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression. Yan J; Li Q; Lievens S; Tavernier J; You J J Virol; 2010 Jan; 84(1):76-87. PubMed ID: 19846528 [TBL] [Abstract][Full Text] [Related]
76. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18. Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772 [TBL] [Abstract][Full Text] [Related]
77. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. Dang C; Koehler A; Forschner T; Sehr P; Michael K; Pawlita M; Stockfleth E; Nindl I Br J Dermatol; 2006 Jul; 155(1):129-36. PubMed ID: 16792764 [TBL] [Abstract][Full Text] [Related]
78. Internal polyadenylation of the parvovirus B19 precursor mRNA is regulated by alternative splicing. Guan W; Huang Q; Cheng F; Qiu J J Biol Chem; 2011 Jul; 286(28):24793-805. PubMed ID: 21622561 [TBL] [Abstract][Full Text] [Related]
79. A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter. Gao C; Pan MM; Lei YJ; Tian LQ; Jiang HY; Li XL; Shi Q; Tian C; Yuan YK; Fan GX; Dong XP BMC Mol Biol; 2012 Feb; 13():5. PubMed ID: 22333459 [TBL] [Abstract][Full Text] [Related]
80. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model. López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]